Eli Lilly and Company (LLY)

251.30
+2.86(+1.15%)
  • Volume:
    1,403,465
  • Bid/Ask:
    251.25/251.34
  • Day's Range:
    248.50 - 254.39

LLY Overview

Prev. Close
248.44
Day's Range
248.5-254.39
Revenue
27.76B
Open
248.7
52 wk Range
129.21-275.87
EPS
6.55
Volume
1,403,465
Market Cap
16.79B
Dividend (Yield)
3.40
(1.39%)
Average Volume (3m)
2,522,410
P/E Ratio
37.95
Beta
0.3
1-Year Change
75.33%
Shares Outstanding
1,170,744,000
Next Earnings Date
03 Feb 2022
What is your sentiment on Eli Lilly and Company?
or
Vote to see community's results!

Eli Lilly and Company News

Eli Lilly and Company Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralBuyBuyStrong BuyStrong Buy
Technical IndicatorsStrong SellBuyStrong BuyStrong BuyStrong Buy
SummarySellBuyStrong BuyStrong BuyStrong Buy

Eli Lilly and Company Company Profile

Eli Lilly and Company Company Profile

Employees
35000

Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include Diabetes and other endocrinology products, including Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. Its Immunology products include Olumiant and Taltz. Its Neuroscience products include Cymbalta, Emgality, Reyvow, Strattera and Zyprexa. Its Oncology products include Alimta, Cyramza, Erbitux and Verzenio. Other product includes Cialis, for the tratment of erectile dysfunction and benign prostatic hyperplasia. The Company manufacture and distribute its products through facilities in the United States, Puerto Rico, and 8 other countries. Its products are sold in approximately 120 countries.

Read More
  • Bullish Eli . Thanks you
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.